<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940603-2-00060</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>[CDC&hyph;464] </RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Announcement of a Cooperative Agreement to the World Health Organization </DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Summary  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The Centers for Disease Control and Prevention (CDC), announces the availability of funds for fiscal year (FY) 1994 for a sole source cooperative agreement with the World Health Organization (WHO) to conduct polio surveillance, provide technical assistance in developing a laboratory network, provide programmatic assistance to carry out operational and applied research, and to provide oral polio vaccine for supplemental immunization activities for the global initiative to eradicate polio by the year 2000. Approximately $1.2 to $1.6 million will be available in FY 1994 to support this project. It is expected the award will begin on July 1, 1994, for a 12-month budget period within a 3-year project period. The funding estimate is subject to change. Continuation awards within the project period will be made on the basis of satisfactory progress and availability of funds. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The purpose of this cooperative agreement is to support the polio eradication initiative by providing technical, laboratory, programmatic consultants, operational and applied research, oral polio vaccine, and other services, as needed, to the governments of polio endemic countries. Specific activities should be in the areas of polio surveillance to define and assess the polio endemic countries, including surveillance for acute flaccid paralysis, development of a laboratory network for poliovirus isolation in developing countries, and assistance to foreign governments in planning and implementing national immunization days and other polio eradication activities. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> CDC will collaborate by providing (1) technical assistance to WHO in support of activities implemented under this agreement; (2) programmatic support to national governments for planning, implementing, and evaluating polio eradication activities; (3) technical training, support, and consultation to expert staff hired by WHO to assist in the polio eradication initiative; (4) expertise for the surveillance to assess, define, and prioritize the assistance needs of polio endemic countries and assist in the development of a laboratory network for poliovirus isolation in developing countries; and (5) other technical assistance in support of this project, as needed. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of Healthy People 2000, a PHS-led national activity to reduce morbidity and mortality and improve the quality of life. This announcement is related to the priority area of Immunization and Infectious Diseases. (For ordering a copy of ``Healthy People 2000,'' see the Section ``Where To Obtain Additional Information.'') <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Authority <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> This program is authorized under sections 301 and 307 of the Public Health Service Act, as amended, 42 U.S.C. 241 and 242 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> l <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , and section 104 of the Foreign Assistance Act of 1961, 22 U.S.C. 2151b.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Smoke-Free Workplace  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The Public Health Service strongly encourages all grant recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. This is consistent with the PHS mission of promoting the protection and advancement of an individual's physical and mental health. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Eligible Applicant <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Eligibility for assistance is limited to the World Health Organization for this project. No other applications are solicited. The program announcement and application kit have been sent to WHO. <!-- PJG 0012 frnewline --> WHO is the most appropriate and qualified agency to conduct the activities under this cooperative agreement because: <!-- PJG 0012 frnewline --> A. WHO has the lead responsibility among the United Nations organizations for implementing the World Health Assembly resolution of 1988 calling for the global eradication of polio by the year 2000. WHO is the only organization with a worldwide mandate for the control and prevention of vaccine preventable diseases.  <!-- PJG 0012 frnewline --> B. The proposed program is strongly supportive of and directly related to the achievement of WHO and CDC/National Immunization Program objectives for the control and prevention of vaccine preventable diseases.  <!-- PJG 0012 frnewline --> C. WHO, together with UNICEF, the Pan American Health Organization, Rotary International, and CDC, is a member of the Polio Eradication Network, an organization formed to increase support and visibility for the polio eradication initiative. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Executive Order 12372 Review <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The application is not subject to review under Executive Order 12372, Intergovernmental Review of Federal Programs. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Public Health System Reporting Requirements <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> This program is not subject to the Public Health System Reporting Requirements.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Catalog of Federal Domestic Assistance Number  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The Catalog of Federal Domestic Assistance Number for this program is 93.185, Immunization Research, Demonstration, Public  <!-- PJG 0012 frnewline --> Information, and Education, Training, and Clinical Skills Improvement Projects.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Other Requirements  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Human Subjects  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> If any of the proposed projects involve research on human subjects, the applicant must comply with the Department of Health and Human Services Regulations, 45 CFR Part 46, regarding the protection of human subjects. Assurance must be provided to demonstrate that the project will be subject to initial and continuing review by an appropriate institutional review committee. The applicant will be responsible for providing assurance in accordance with the appropriate guidelines and form provided in the application kit.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Where to Obtain Additional Information  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> If you are interested in obtaining additional information regarding this project, please refer to Announcement 464 and contact Carole J. Tully, Grants Management Specialist, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE., room 300, Mailstop E&hyph;09, Atlanta, GA 30305, telephone (404) 842&hyph;6880.  <!-- PJG 0012 frnewline --> A copy of ``Healthy People 2000'' (Full Report, Stock No. 017&hyph;001&hyph;00474&hyph;0) or ``Healthy People 2000'' (Summary Report, Stock No. 017&hyph;001&hyph;00473&hyph;1) referenced in the ``Summary'' may be obtained through  <!-- PJG 0012 frnewline --> the Superintendent of Documents, Government Printing Office, Washington, DC 20402&hyph;9325, telephone (202) 783&hyph;3238.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: May 27, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Ladene H. Newton, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Acting Associate Director for Management  <!-- PJG 0012 frnewline --> and Operations,  <!-- PJG 0012 frnewline --> Centers for Disease Control and  <!-- PJG 0012 frnewline --> Prevention (CDC). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;13494 Filed 6&hyph;2&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4163&hyph;18&hyph;P <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            